MENU
ANVS
AS OF
Feb 4, 04:59 PM (EDT)
Price
$2.59
Change
-$0.01 (-0.38%)
Capitalization
68.91M
47 days until earnings call
Intraday BUY SELL Signals
+Compare
ANVS
Stock ticker: NYSE
AS OF
Feb 4, 04:59 PM (EDT)
Price
$2.59
Change
-$0.01 (-0.38%)
Capitalization
68.91M

ANVS Annovis Bio Forecast, Technical & Fundamental Analysis

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases... Show more

ANVS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ANVS with price predictions
Feb 03, 2026

ANVS in -11.18% downward trend, declining for three consecutive days on January 30, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ANVS declined for three days, in of 310 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ANVS as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

ANVS moved below its 50-day moving average on January 12, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ANVS crossed bearishly below the 50-day moving average on January 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The Aroon Indicator for ANVS entered a downward trend on January 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for ANVS's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ANVS advanced for three days, in of 250 cases, the price rose further within the following month. The odds of a continued upward trend are .

ANVS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.238) is normal, around the industry mean (27.519). P/E Ratio (0.000) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (331.843).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ANVS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANVS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ANVS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ANVS is expected to report earnings to fall 7.49% to -34 cents per share on March 23

Annovis Bio ANVS Stock Earnings Reports
Q4'25
Est.
$-0.34
Q3'25
Missed
by $0.06
Q2'25
Beat
by $0.08
Q1'25
Beat
by $0.06
Q4'24
Missed
by $0.11
The last earnings report on November 12 showed earnings per share of -37 cents, missing the estimate of -31 cents. With 240.67K shares outstanding, the current market capitalization sits at 68.91M.
A.I. Advisor
published General Information

General Information

a developer of drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
101 Lindenwood Drive
Phone
+1 484 875-3192
Employees
6
Web
https://www.annovisbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NPRLF0.780.03
+3.45%
North Peak Resources Ltd.
BBSEY7.440.22
+3.05%
BB Seguridade Participacoes SA
CNND213.00N/A
N/A
Canandaigua National Corp.
TOIPF0.75N/A
N/A
Thai Oil Public Co., Ltd.
LEEN0.18N/A
N/A
Leopard Energy, Inc.

ANVS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
-3.70%
ADXN - ANVS
43%
Loosely correlated
+0.65%
ALGS - ANVS
39%
Loosely correlated
-5.41%
MDGL - ANVS
36%
Loosely correlated
-1.49%
VYGR - ANVS
36%
Loosely correlated
-2.25%
BDTX - ANVS
35%
Loosely correlated
-0.79%
More